NHS Logo
  • Home
  • Impact
  • About Us
    • Contact Us
    • NIHR Imperial BRC Team
    • Equality, Diversity and Inclusion (EDI) Strategy
    • NIHR Infrastructures
    • Acknowledgement
    • Research Guidance & Useful Links
    • NIHR Imperial BRC Branding Guidance
  • Research
    • Biomedical Engineering
    • Brain Sciences
    • Cardiovascular
    • Digestive Diseases
    • Digital Health
    • Immunology
    • Infection & Antimicrobial Resistance
    • Metabolic & Endocrinology
    • Molecular Phenotyping
    • Multiple Long-term Conditions (MLTC)
    • Pregnancy & Prematurity
    • Respiratory
    • Social, Genetic & Environmental Determinants of Health (SGE)
    • Surgery & Cancer
  • Facilities/Services
    • Clinical Imaging Facility
    • Clinical Phenotyping Centre
    • Flow Cytometry
    • Genomics Facility
    • Imperial College Healthcare Tissue Bank
    • iCARE
    • Imperial Clinical Trials Unit
    • Imperial Health Knowledge Bank (IHKB)
    • Organoid Facility
    • Patient Experience Research Centre (PERC)
    • The Leonard and Dora Colebrook Laboratory
  • Patient/Public
    • Research We Are Supporting
    • How You Can Get Involved
    • Information for Researchers
    • Public Involvement, Engagement and Participation in Research Summary Strategy
  • Industry/Partners
    • Primary Care Research Unit/Centre
    • Collaborations
    • Contract
    • Commercialisation
  • Training
    • Non-Medical Opportunities
    • Chain Florey Clinician Scientist Programme
    • Clinical Academic Training Office
    • Other Training Schemes
  • News & Events
    • Upcoming Events
    • Newsletter

Partnership Stories

PartnershipTherapeutic Partnering with Heptares to accelerate translational research in gastrointestinal disease

PartnershipTherapeutic Partnering with Heptares to accelerate translational research in gastrointestinal disease

Published on 22nd January 2018
First in HumanInnovationPartnershipTherapeutic Imperial-developed cancer drug enters phase I clinical trial

First in HumanInnovationPartnershipTherapeutic Imperial-developed cancer drug enters phase I clinical trial

Published on 12th January 2018
DeviceInnovationPartnershipTherapeutic Imperial spinout GripAble™ launches to improve physical rehabilitation

DeviceInnovationPartnershipTherapeutic Imperial spinout GripAble™ launches to improve physical rehabilitation

Published on 29th November 2017
PartnershipPreventionTherapeutic Nutrition and Food Network launched

PartnershipPreventionTherapeutic Nutrition and Food Network launched

Published on 9th November 2017
PartnershipTherapeutic Reducing drug dosage in CML patients in deep remission

PartnershipTherapeutic Reducing drug dosage in CML patients in deep remission

Published on 9th November 2017
Information for Patients and the Public
  • Research We Are Supporting
  • How You Can Get Involved
  • Public Involvement, Engagement and Participation in Research Summary Strategy
Latest News
  • Device Wearable Tech Offers New Hope for Stroke Survivors Seeking to Regain Mobility
  • Prevention Suicide Risk in England Tied to Deprivation and Transport Density
  • DiagnosticPreventionTreatment Uniting Across Borders to Combat HTLV-1 in Africa
NIHR Imperial Biomedical Research Centre

The National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre (BRC) is part of the NIHR and hosted by Imperial College Healthcare NHS Trust in partnership with Imperial College London


Accessibility
Privacy
Terms & Conditions

The information contained in this website is for general use only. We endeavour to keep the information on the site up to date and correct, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose.

© 2025 - NIHR Imperial Biomedical Research Centre